Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10920116 | Radiotherapy and Oncology | 2005 | 7 Pages |
Abstract
Despite not suggesting a survival benefit for the sequential addition of chemotherapy to radical radiotherapy, possibly because of the relatively small sample size and consequently wide confidence intervals, the results can still be regarded as consistent with the meta-analysis, and other similarly designed recently published large trials. Combining all these results suggests there may be a small median survival benefit with chemotherapy of between 2 and 8 weeks.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
David Fairlamb, Robert Milroy, Nicole Gower, Mahesh Parmar, Michael Peake, Robin Rudd, Robert Souhami, Stephen Spiro, Richard Stephens, David Waller, on behalf of all BLT participants on behalf of all BLT participants,